4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-071500
Chief Operating Officer sold 3,702 shares at an average $20.00 ($74,045)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2024-06-07 | Sale 10b5-1 | −200 | $20.00 | $4,000 | 431,483 | D: show line 1 in the form |
| Bensen Daniel Chief Operating Officer | 2024-06-10 | Sale 10b5-1 | −3,502 | $20.00 | $70,045 | 427,981 | D: show line 2 in the form |
| Open-market sales · 3,702 sh · avg $20.00 · $74,045 | |||||||
Loading xslF345X05/ownership.xml…